Identification of Ferroptosis-Related Gene Prognostic Signature and HSF1 for Reversing Doxorubicin and Gemcitabine Resistance in Uterine Carcinosarcoma

Figure 6

Inhibition of HSF1 expression increased gemcitabine- or doxorubicin-induced ferroptosis. (a, b) Analysis of intracellular lipid ROS when HSF1 knockdown combined with treatment with gemcitabine or doxorubicin in MES-SA and FU-MMT-1 cells. (c, d) Analysis of intracellular iron levels when HSF1 knockdown combined with treatment with gemcitabine or doxorubicin in MES-SA and FU-MMT-1 cells.

(a)

(b)

(c)

(d)